gatipotuzumab
- Generic Name
- gatipotuzumab
PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Primary Peritoneal CancerFallopian Tube CancerOvarian Epithelial Cancer Recurrent
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Glycotope GmbH
- Target Recruit Count
- 216
- Registration Number
- NCT01899599
- Locations
- 🇬🇧
Investigator, Sutton, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath